europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio

23/05/2022
PRESS RELEASE
Brussels, 23 May 2022 – EuropaBio is delighted to announce that Jamie Wilkinson has been appointed as the new Healthcare Biotechnology Director at EuropaBio.

Jamie is a pharmacist with an extensive experience in European and global health and pharmaceutical policies. He has experience navigating the health policy ecosystem in Brussels and beyond - gained from policy roles in non-governmental organisations, professional and patient-led organisations, trade associations, and pharmaceutical and biotechnology companies. He holds a Professional Diploma in Public Relations, master’s degrees in pharmacy, health policy, and public health, as well as professional registrations in public health, regulatory policy, public relations, and pharmacy.

Speaking about his appointment, Jamie said: "I am excited to join EuropaBio at a pivotal time of European pharmaceutical policy revision, and to contribute to the healthcare policy transformation that will boost innovation, create the right environment to attract investments, and deliver biotechnology excellence in Europe."

Claire Skentelbery, Director General of EuropaBio commented: "We are delighted to welcome Jamie to the team as Healthcare Biotechnology Director. He will work across members to implement their policy priorities and drive ambitious advocacy strategies for a healthcare regulatory framework in Europe that delivers its full promise to patients, economic development and next generation technologies."

Jamie will take on the new role with immediate effect.

Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio


Download
2022_05_HC_PR_New-HC-Director-1Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

24/05/2023

SwedenBIO joins EuropaBio: helping innovative companies succeed!


Read more
24/05/2023

Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids


Read more
23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more
10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee


Read more

Important links

  • SwedenBIO joins EuropaBio: helping innovative companies succeed!
  • Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies